About
1,415,000.00KRW+20000.00 +1.43%
Closed • Updated at 21:15 GMT+00:00Market Cap$42.56B
P/E Ratio34.86
Volume65.3K
Beta0.33
RSI42.24
Gross Margin55.52%
Samsung Biologics Co., Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
May 20 2026
Samsung Biologics : 2025 FY Audited Financial Statements (Consolidated)
May 6 2026
Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline
May 5 2026
Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year
Apr 22 2026
Samsung Biologics Reports First Quarter 2026 Financial Results
Mar 31 2026
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland
Translate